Humatica AG was retained to advise Capvis on its majority investment stake in Xovis, the global leader in people flow measurement and analytics. With the support of Capvis, Xovis’ management will continue to focus on growth and plans to enter new markets and business segments.
Humatica provided organisational due diligence services for this transaction.
To view the Press Release: Humatica advises Capvis on their recent investment in Xovis
CEO Succession: How to avoid the pitfalls and unlock the value Poorly managed CEO and C-suite transitions in the S&P 1500 companies are estimated to…
Read more
Humatica is pleased to announce three promotions in its London office. Stephanie Hilders and Richard Breitschwerdt have been promoted to Consultant, and Juan Zapardiel has…
Read more
Continuation Funds Surge Continuation fund transactions surged to $63 billion in 2024, driven by a liquidity drought that left 29,000 unsold portfolio companies globally, valued…
Read more